Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...

The decision means many Americans without underlying conditions may not have access to updated shots this fall."I think we ...

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...

The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...

The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...